#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA


March 26, 2020 — The Radiological Society of North America (RSNA) has published an expert consensus statement on reporting chest computed tomography (CT) findings related to COVID-19. The statement, published in Radiology: Cardiothoracic Imaging, is endorsed by the RSNA, the American College of Radiology and the Society of Thoracic Radiology.

“We believe it is important to provide radiologists and referring providers guidance and confidence in reporting these findings and a more consistent framework to improve clarity,” said Suhny Abbara M.D., editor of Radiology: Cardiothoracic Imaging and professor of radiology and chief of the Cardiothoracic Imaging Division at UT Southwestern Medical Center in Dallas, Texas. “Clear evidence-based communication among health care providers, including radiologists, is imperative to improving patient care during this pandemic.”

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become increasingly prevalent worldwide, reaching a pandemic stage in March 2020.

While routine screening CT for the identification of COVID-19 pneumonia is currently not recommended by most radiology societies, the number of CTs performed in patients under investigation for COVID-19 has increased. Some patients may have incidentally detected findings that could be attributable to COVID-19 pneumonia, requiring radiologists to decide whether to mention COVID-19 specifically as a differential diagnostic possibility.

COVID-19 pneumonia, which has a high mortality rate among the elderly and those with diabetes, hypertension, and other comorbidities, is spreading rapidly in communities. As a result, including “COVID-19” frequently in radiology report could trigger a cascade of events including infection control measures and anxiety for both the clinician and patient. Importantly, CT imaging features of COVID-19 can overlap significantly with other causes of acute lung injury and pneumonia, complicating interpretations.

The consensus statement, developed by experts at nine U.S. academic medical centers, aims to help radiologists recognize findings of COVID-19 pneumonia and provide guidance on reporting CT findings potentially associated with COVID-19, including standardized language to reduce reporting variability.

Standardized reporting language will improve communication with referring providers and has the potential to enhance efficiency and reduce anxiety in management of patients during the pandemic.

The paper discusses the potential role of CT in COVID-19, parameters for structured reporting, and the pros, cons and limitations of adopting this strategy.

Because practice patterns may vary by institution, the document is meant to serve as a guide. The authors recommend that radiologists consult with clinical colleagues at their institutions to establish a consensus reporting approach.

For more information: www.rsna.org

Related Coronavirus Content:

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now